These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 32293578)
21. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia. Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184 [TBL] [Abstract][Full Text] [Related]
22. Special clinical characteristics and outcomes in Chinese pediatric patients with early-onset Crohn's disease. Tang WJ; Shi P; Zheng CF; Shi JR; Qiu XX; Wang SN; Huang Y J Dig Dis; 2019 Oct; 20(10):539-546. PubMed ID: 31347264 [TBL] [Abstract][Full Text] [Related]
23. Change in the diagnosis of inflammatory bowel disease: a hospital-based cohort study from Korea. Lee HS; Choe J; Lee HJ; Hwang SW; Park SH; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH; Yang SK Intest Res; 2016 Jul; 14(3):258-63. PubMed ID: 27433148 [TBL] [Abstract][Full Text] [Related]
24. Characterization of inflammatory bowel disease in Colombia: Results of a national register. Juliao-Baños F; Puentes F; López R; Saffon MA; Reyes G; Parra V; Galiano MT; Barraza M; Molano J; Álvarez E; Corrales R; Vargas LE; Gil F; Álvarez P; Limas L; Prieto R; Yance P; Díaz F; Bareño J; ; Rev Gastroenterol Mex (Engl Ed); 2021; 86(2):153-162. PubMed ID: 32723624 [TBL] [Abstract][Full Text] [Related]
26. Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease. Kariyawasam VC; Kim S; Mourad FH; Selinger CP; Katelaris PH; Brian Jones D; McDonald C; Barr G; Chapman G; Colliwshaw J; Lunney PC; Middleton K; Wang RR; Huang T; Andrews J; Pathirana PW; Leong RW Inflamm Bowel Dis; 2019 Jul; 25(8):1390-1398. PubMed ID: 30597066 [TBL] [Abstract][Full Text] [Related]
27. Predictors of Anti-TNF Therapy Failure among Inflammatory Bowel Disease (IBD) Patients in Saudi Arabia: A Single-Center Study. Alharbi O; Aljebreen AM; Azzam NA; Almadi MA; Saeed M; HajkhderMullaissa B; Asiri H; Almutairi A; AlRuthia Y J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887921 [TBL] [Abstract][Full Text] [Related]
29. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients. Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570 [TBL] [Abstract][Full Text] [Related]
30. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease]. Kujundzić M Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303 [TBL] [Abstract][Full Text] [Related]
31. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study). Henriksen M; Jahnsen J; Lygren I; Sauar J; Schulz T; Stray N; Vatn MH; Moum B; Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716 [TBL] [Abstract][Full Text] [Related]
32. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry. Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168 [TBL] [Abstract][Full Text] [Related]
33. Mortality Risk of Inflammatory Bowel Disease: A Case-Control Study of New York State Death Records. Nocerino A; Feathers A; Ivanina E; Durbin L; Swaminath A Dig Dis Sci; 2019 Jun; 64(6):1604-1611. PubMed ID: 30604370 [TBL] [Abstract][Full Text] [Related]
34. Risk of Myocardial Infarction in Inflammatory Bowel Disease: A Population-based National Study. Panhwar MS; Mansoor E; Al-Kindi SG; Sinh P; Katz J; Oliveira GH; Cooper GS; Ginwalla M Inflamm Bowel Dis; 2019 May; 25(6):1080-1087. PubMed ID: 30500938 [TBL] [Abstract][Full Text] [Related]
35. P044 A Profile of New Start IBD Patients on Multiple Advanced/Biologic Therapies. John E Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S11. PubMed ID: 37461962 [TBL] [Abstract][Full Text] [Related]
37. [The role of smoking as a risk factor in inflammatory bowel diseases: single center study in Korea]. Jang JY; Kim HJ; Jung JH; Chae MJ; Kim NH; Lee SK; Joo KR; Dong SH; Kim BH; Chang YW; Lee JI; Chang R Korean J Gastroenterol; 2006 Mar; 47(3):198-204. PubMed ID: 16554673 [TBL] [Abstract][Full Text] [Related]
39. Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center. Szántó K; Nyári T; Bálint A; Bor R; Milassin Á; Rutka M; Fábián A; Szepes Z; Nagy F; Molnár T; Farkas K PLoS One; 2018; 13(7):e0200824. PubMed ID: 30059523 [TBL] [Abstract][Full Text] [Related]
40. Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease. Choi YI; Kim TJ; Park DK; Chung JW; Kim KO; Kwon KA; Kim YJ Int J Colorectal Dis; 2019 Oct; 34(10):1713-1721. PubMed ID: 31471699 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]